White Paper: Five translational insights key to a successful first-in-human (FIH) study
22 September 2021
As you move forward toward early clinical trials, having clear translational insight can be enormously important. As a methodology, metabolomics is uniquely qualified to help you bridge between the theoretical and practical, between the function and actual activity of your drug molecule. Finally, collaborating with a proven metabolomics expert like Metabolon can complement and extend the work of your in-house teams, and make their efforts more efficient in your overall program. Download the white paper below to find out how you can use metabolomics to enhance drug development.